Catalyst Pharmaceuticals (CPRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist

17.590
+0.220+1.27%

Close Jul 26 16:00 ET

17.410
-0.180-1.02%

Post 20:01 ET

2.08BMarket Cap31.41P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Catalyst Sells Canadian Rights to Duchenne Drug to Kye Pharma
Seeking AlphaJul 24 14:22 ET
Express News | Catalyst Pharmaceuticals Enters Exclusive License, Supply And Commercialization Agreement Granting Kye Pharmaceuticals Canadian Rights To AGAMREE For Duchenne Muscular Dystrophy
BenzingaJul 24 08:10 ET
Express News | Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement With Kye Pharmaceuticals for Agamree® in Canada
ReutersJul 24 08:05 ET
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement With Kye Pharmaceuticals for AGAMREE in Canada
Catalyst PharmaceuticalsJul 24 00:00 ET
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
Catalyst PharmaceuticalsJul 22 00:00 ET
These Small-cap Stocks Score Highest When Screened for Quality
MarketWatchJul 17 11:57 ET

Comments

Trytosaveabit

Jul 24 07:12

Update

$Catalyst Pharmaceuticals(CPRX.US)$ Catalyst Pharmaceuticals Enters Exclusive License, Supply And Commercialization Agreement Granting Kye Pharmaceuticals Canadian Rights To AGAMREE For Duchenne Muscular Dystrophy

Meltyy

May 24 03:20

See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb(BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna(MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals(CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline(GSK.US)$ : Arexvy
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals(REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US)$ : Augtyro...

Trytosaveabit

May 8 15:21

Solid

$Catalyst Pharmaceuticals(CPRX.US)$ May 08 (Reuters) - Catalyst Pharmaceuticals Q1 Net Income USD 23.3 Million.
Q1 Adjusted Net Income USD 46.8 Million Vs. Ibes Estimate USD 23.7 Million
Q1 Operating Income USD 27.1 Million Vs. Ibes Estimate USD 25.1 Million
Outlook FY Revenue USD 455-475 Million

Moomoo AI

Mar 22 09:45

The absence of insider buying at Catalyst Pharmaceuticals over the past year is concerning. However, the high level of insider ownership indicates alignment with shareholder interests. Insider selling, even below the current price, raises questions about their view on the company's valuation.